Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Hemangioendothelioma, Epithelioid × Proton Therapy × Clear all

Sponsor

Conditions

Carcinoma, Non-Small-Cell Lung 5 Prostatic Neoplasms 4 Glioblastoma 3 Brain Neoplasms 3 Sarcoma 2 Pancreatic Neoplasms 2 Neoplasms 2 Lung Neoplasms 2 Gliosarcoma 2 Glioma 2 Urothelial Carcinoma of the Bladder 1 Thoracic Neoplasms 1 Stage IA-IIA Breast Cancer 1 Rhabdomyosarcoma 1 Retinoblastoma 1 Recurrence 1 Neuroectodermal Tumors, Primitive, Peripheral 1 Meningioma 1 Lymphoma, Non-Hodgkin 1 Lymphoma 1 Gastrointestinal Neoplasms 1 Eye Neoplasms 1 Esophageal Neoplasms 1 Ependymoma 1 Desmoplastic Small Round Cell Tumor 1 Chordoma 1 Chondrosarcoma 1 Central Nervous System Neoplasms 1 Carcinoma, Hepatocellular 1 Breast Neoplasms 1

Interventions

tremelimumab 1 trametinib 1 pazopanib 1 eribulin 1 durvalumab 1 HhAntag691 1 Gemcitabine 1 2,2-dimethyl-N-(6-oxo-6,7-dihydro-5H-dibenzo(b,d)azepin-7-yl)-N'-(2,2,3,3,3-pentafluoropropyl)malonamide 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡